Once-Daily Tiotropium Respimat® Add-on to at Least Ics Maintenance Therapy Demonstrates Improved Lung Function in Patients with Symptomatic Asthma, Independent of Serum IgE or Blood Eosinophil Levels

2016 ◽  
Vol 137 (2) ◽  
pp. AB213 ◽  
Author(s):  
Donald P. Tashkin ◽  
Ronald Dahl ◽  
Johann Christian Virchow ◽  
Michael Engel ◽  
Petra Moroni-Zentgraf ◽  
...  
Keyword(s):  
Lung Function ◽  
Maintenance Therapy ◽  
Blood Eosinophil ◽  
Once Daily ◽  
Serum Ige ◽  
Symptomatic Asthma

Once-Daily Tiotropium Respimat® Improves Lung Function In Patients With Severe Symptomatic Asthma Independent Of Leukotriene Modifier Use

2014 ◽  
Vol 133 (2) ◽  
pp. AB5 ◽  
Author(s):  
Ronald Dahl ◽  
Dennis E. Doherty ◽  
Jonathan Corren ◽  
Jill Karpel ◽  
Huib A.M. Kerstjens ◽  
...  
Keyword(s):  
Lung Function ◽  
Once Daily ◽  
Symptomatic Asthma

Once-daily tiotropium Respimat add-on to at least ICS maintenance therapy reduces exacerbation risk in patients with uncontrolled symptomatic asthma

Pneumologie ◽  
2015 ◽  
Vol 69 (S 01) ◽  
Author(s):  
O Schmidt ◽  
D Halpin ◽  
E Bateman ◽  
P Paggiaro ◽  
E Bleecker ◽  
...  
Keyword(s):  
Maintenance Therapy ◽  
Once Daily ◽  
Symptomatic Asthma ◽  
Exacerbation Risk
Sign in / Sign up

Export Citation Format

Share Document